Table 1A.

Comparison of polymyalgia rheumatica (PMR) criteria. Adapted from Dasgupta, et al. Arthritis Rheum 2006;55:518–209; with permission.

Bird & WoodChuang & HunderHealeyJones & HazlemanEULAR/ACR without MSUSEULAR/ACR with MSUS
(1)Age, yrs> 65≥ 50> 50≥ 50 (obligatory)≥ 50 (obligatory)
(2)Bilateral pain of neck, shoulders, and pelvic girdleShouldersAny 2AnyShoulders and pelvic girdleShoulders (obligatory) Hips (1 point)Shoulders (obligatory) Hips (1 point)
(3)ESR≥ 40 mm/h> 40 mm/hElevated> 30 mm/h and/or CRP > 6 mg/lElevated ESR and/or CRP (obligatory)Elevated ESR and/or CRP (obligatory)
(4)Morning stiffness> 1 h≥ 30 min> 1 hYes> 45 min (2 points)> 45 min (2 points)
(5)Duration of symptomsRapid onset < 2 weeks≥ 1 mo≥2 mo unless treated
(6)Depression and/or weight lossYes
(7)Bilateral upper arm tendernessYes
(8)Exclusion of other diagnosesYesAbsence of RF and ANAYesAbsence of RF or ACPA (2 points) Absence of other joint involvement (1 point)Absence of RF or ACPA (2 points) Absence of other joint involvement (1 point)
(9)Rapid response to corticosteroids≤ 20 mg prednisoneYes
(10)MSUS1 shoulder and 1 hip (1 point) Both shoulders (1 point)
DiagnosisAny 3All above(1) and (8) obligatory, plus any 3 of (2), (3), (4) or (9)All above(1), (2) and (3) obligatory, plus a score of 4 or more points(1), (2) and (3) obligatory, plus a score of 5 or more points
  • EULAR/ACR: European League Against Rheumatism/American College of Rheumatology criteria for PMR; MSUS: musculoskeletal ultrasound; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; RF: rheumatoid factor; ACPA: anti-citrullinated protein antibody; ANA: antinuclear antibodies.